首页 > 市场调查报告书 > 製药

消化器

北美急性胰臟炎市场预测至 2030 年 - 区域分析 - 按产品、原因和最终用户

市场调查报告书

商品编码

1452546

北美急性胰臟炎市场预测至 2030 年 - 区域分析 - 按产品、原因和最终用户

North America Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

出版日期: 2024年01月03日 | 出版商:

The Insight Partners | 英文 94 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美急性胰臟炎市值为32.0963亿美元，预计到2030年将达到5,00071万美元；预计2022年至2030年CAGR为5.7%。

急性胰臟炎引起的胰臟癌病例增加推动了北美急性胰臟炎市场

胰臟癌是西方国家癌症相关死亡的第四大原因。根据美国癌症协会《2022 年癌症事实与数据》，预计到 2030 年，胰臟癌的死亡率将成为美国所有癌症死亡率中第二高的癌症。如果不及早发现，胰臟癌更有可能进展。肿瘤是可以切除的。根据 2021 年国家医学图书馆发表的一篇文章，只有约 15% 的胰臟肿瘤在诊断时可以切除，五年存活率限制在 8%。然而，缺乏早期症状导致这些肿瘤的诊断不佳和可切除性较低。急性胰臟炎可能导致胰臟癌，因为它是胰臟癌的早期症状，近 1% 的急性胰臟炎入院患者会被诊断为胰臟癌。这些患者在诊断出急性胰臟炎后需要几个月的时间才能被诊断为胰臟癌，但有些患者因最初的误诊而遭受更长的诊断延误，这可能会阻碍他们的康復。急性胰臟炎反覆发生会导致慢性胰臟炎，可能进一步增加胰臟癌的风险。

根据美国国家糖尿病、消化和肾臟疾病研究所的数据，急性胰臟炎每年导致约 275,000 人入院，而这一数字在美国一直在增加。在美国，约 35-40% 的急性胰臟炎病例是由胆结石引起的，而饮酒是造成 30% 病例的原因。 80% 的入院患者的胰臟炎通常是轻度的，大多数可以在住院几天内出院。急性胰臟炎的死亡率约为 2%，復发率在 0.6% 至 5.6% 之间。酒精相关性胰臟炎的復发率最高。根据2022年发表在《刺胳针胃肠病学肝病学》上的一篇文章，全球急性胰臟炎的总发病率为每年每10万人中34例。北美每年每 10 万人中有 58.2 例（美国每年每 10 万人有 58.2 例），而欧洲的瑞典和丹麦分别为每 10 万人 24.7 例和 15.0 例。

急性胰臟炎会导致消化酵素释放到胰臟间质而不是胰管腔中，由于肿瘤阻塞胰管，急性胰臟炎可能是胰臟癌的早期指标。急性胰臟炎是一种痛苦的疾病，因此患者应儘早医，这可能有助于早期癌症诊断。因此，急性胰臟炎引起的胰臟癌病例的增加促进了北美急性胰臟炎市场的成长。

北美急性胰臟炎市场概况

北美急性胰臟炎市场分为美国、加拿大和墨西哥。 2022年，美国在该地区占据最大市场份额，预计在预测期内将继续保持主导地位。北美急性胰臟炎市场预计将成长，因为胆结石病例增加和过量饮酒导致急性胰臟炎负担增加。此外，随着医疗保健设施技术进步的增加，北美市场预计在预测期内将成长。

北美急性胰臟炎市场收入及 2030 年预测（百万美元）

北美急性胰臟炎市场细分

北美急性胰臟炎市场按产品、原因、最终用户和国家进行细分。

根据产品类型，北美急性胰臟炎市场分为药物、诊断等。 2022年，诊断细分市场占据最大市场份额。

根据病因，北美急性胰臟炎市场分为胆结石、酗酒、遗传性疾病、感染等。 2022 年，胆结石细分市场占据最大的市场份额。

根据最终用户，北美急性胰臟炎市场分为医院、诊断实验室、门诊手术中心等。 2022 年，医院细分市场占据最大市场份额。

根据国家/地区，北美急性胰臟炎市场分为美国、加拿大和墨西哥。 2022年，美国在北美急性胰臟炎市场份额中占据主导地位。

Abbott Laboratories、Baxter International Inc、Boston Scientific Corp、Dynavax Technologies Corp、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、Medtronic Plc 和 Samsung Healthcare 是北美急性胰臟炎市场的一些领先公司。

主要市场驱动因素
- 急性胰臟炎导致胰臟癌病例增加
- 急性胰臟炎后糖尿病发生率上升
主要市场限制
- 胰臟炎和胰臟癌治疗的副作用
主要市场机会
- 急性胰臟炎的研发活动和宣传项目数量激增
未来的趋势
- 特异性急性胰臟炎治疗的进展
影响分析：

第 6 章：急性胰臟炎市场 - 北美市场分析

北美急性胰臟炎市场收入，2022 - 2030

第 7 章：北美急性胰臟炎市场 - 收入和 2030 年预测 - 按产品分类

概述
2022 年及 2030 年北美急性胰臟炎市场收入份额（按产品划分）
药物
诊断
其他的

第 8 章：北美急性胰臟炎市场 - 收入和 2030 年预测 - 按原因

概述
2022 年及 2030 年北美急性胰臟炎市场收入份额（按原因划分）
胆结石
酗酒
遗传性疾病
感染
其他的

第 9 章：北美急性胰臟炎市场 - 收入和 2030 年预测 - 按最终用户

概述
北美急性胰臟炎市场收入份额（按最终用户），2022 年和 2030 年 (%)
医院
诊断实验室
门诊手术中心
其他的

第 10 章：北美急性胰臟炎市场 - 国家分析

概述

第 11 章：北美急性胰臟炎市场-产业格局

概述
北美急性胰臟炎市场的成长策略
无机成长策略
- 概述
有机成长策略
- 概述

第 12 章：公司简介

Abbott Laboratories
GE HealthCare Technologies Inc
Samsung Healthcare
Koninklijke Philips NV
Baxter International Inc
Dynavax Technologies Corp
Medtronic Plc
Boston Scientific Corp
Fresenius Kabi AG

第 13 章：附录

简介目录图表

Product Code: BMIRE00029237

The North America acute pancreatitis market was valued at US$ 3,209.63 million in 2022 and is expected to reach US$ 5,000.71 million by 2030; it is estimated to grow at a CAGR of 5.7% from 2022 to 2030.

Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis Fuels the North America Acute Pancreatitis Market

Pancreatic cancer is the fourth leading cause of cancer-related mortality in Western countries. According to the American Cancer Society, Cancer Facts & Figures 2022, the mortality rate of pancreatic cancer is predicted to be the second highest among all cancer-led mortality rates in the US by 2030. It is more likely to progress if not detected early when the tumor is resectable. According to an article published in the National Library of Medicine in 2021, only ~15% of pancreatic tumors are resectable at diagnosis, limiting five-year survival to 8%. However, the lack of early symptoms results in poor diagnosis and low resectability of these tumors. Acute pancreatitis may cause pancreatic cancer as it is an early symptom of pancreatic cancer, nearly 1% of acute pancreatitis admissions result in pancreatic cancer diagnoses. It takes several months for these patients to be diagnosed with pancreatic cancer after acute pancreatitis is diagnosed, but some suffer longer diagnostic delays due to initial misdiagnosis, which may hinder their recovery. Recurrent occurrence of acute pancreatitis leads to chronic pancreatitis, which may further increase the risk of pancreatic cancer.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, acute pancreatitis leads to ~275,000 hospital admissions each year, and this number has been increasing in the US. ~35-40% of acute pancreatitis cases in the US are due to gallstones, while alcohol consumption is the cause of 30% of cases. Pancreatitis is usually mild in 80% of patients who are admitted, and most can be discharged within a few days of their hospitalization. Acute pancreatitis is associated with a mortality rate of ~2% and has a relapse rate between 0.6% and 5.6%. Alcohol-related pancreatitis has the highest rate of relapse. According to an article published in Lancet Gastroenterology Hepatology in 2022, the global pooled incidence of acute pancreatitis is 34 cases per 100,000 per year. North America has 58.2 cases per 100,000 people per year (the US has 58.2 cases per 100,000 people per year) while Europe has 24.7 and 15.0 cases per 100,000 people in Sweden and Denmark, respectively.

Acute pancreatitis, which causes the release of digestive enzymes into the pancreatic interstitial space instead of the pancreatic duct lumen, could be an early indicator of pancreatic cancer due to tumor obstruction of the pancreatic duct. Acute pancreatitis is a painful condition, so patients seek medical care sooner, which could lead to an early cancer diagnosis. Therefore, rising cases of pancreatic cancer due to acute pancreatitis boosts the growth of the North America acute pancreatitis market.

North America Acute Pancreatitis Market Overview

The North America acute pancreatitis market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. the North America acute pancreatitis market in North America is expected to grow due to the increasing burden of acute pancreatitis due to increase in cases of gallstones and excessive consumption of alcohol. Also, with an increase in technological advancement in healthcare facilities, the market in North America is expected to grow during the forecast period.

North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

North America Acute Pancreatitis Market Segmentation

The North America acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the North America acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on causes, the North America acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the North America acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America acute pancreatitis market is segmented into the US, Canada, and Mexico. The US dominated the North America acute pancreatitis market share in 2022.

Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the North America acute pancreatitis market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 North America Acute Pancreatitis Market, by Country (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Acute Pancreatitis Market Landscape

4.1 Overview

5. North America Acute Pancreatitis Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:

6. Acute Pancreatitis Market - North America Market Analysis

6.1 North America Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. North America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

7.1 Overview
7.2 North America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 North America Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 North America Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

8.1 Overview
8.2 North America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 North America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Acute Pancreatitis Market - Country Analysis

10.1 Overview

11. North America Acute Pancreatitis Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the North America Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Medtronic Plc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Boston Scientific Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Fresenius Kabi AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Acute Pancreatitis Market Segmentation
Table 2. North America Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
Table 4. US: North America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 5. US: North America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 6. US: North America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 7. US: North America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 8. US: North America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: North America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada: North America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada: North America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada: North America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada: North America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico: North America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico: North America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico: North America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico: North America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 18. Mexico: North America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Recent Inorganic Growth Strategies in the North America Acute Pancreatitis Market
Table 20. Recent Organic Growth Strategies in the North America Acute Pancreatitis Market
Table 21. Glossary of Terms, North America Acute Pancreatitis Market

List Of Figures

Figure 1. North America Acute Pancreatitis Market Segmentation, By Country
Figure 2. North America Acute Pancreatitis Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. North America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Acute Pancreatitis Market, by Key Country - Revenue (2022) (US$ Million)
Figure 21. North America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. US: North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Canada: North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Mexico: North America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies in the North America Acute Pancreatitis Market